3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Contrast-Enhanced CT in Patients With Kidney Disease: Some Considerations in Response to the ACR/NKF Consensus

      letter
      , MD 1 , , MD 2
      Kidney Medicine
      Elsevier

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To the Editor: We read with interest the American College of Radiology/National Kidney Foundation (ACR/NKF) consensus statements 1 and would like to emphasize the following points. • The low risk perception is mostly based on retrospective propensity-matched analyses, hardly “well-controlled” with potential selection bias, and has been graded as low evidence 2 • We believe that more research is needed on biomarkers indicating early structural kidney damage induced by contrast material and on acute kidney injury (AKI) definition 3 , 4 • All referenced retrospective studies used iso-osmolar contrast media (IOCM) and low-osmolar contrast media (LOCM); however, IOCM was used in high-risk patients. LOCM was acknowledged as a significant risk factor at estimated glomerular filtration rates (eGFRs) ≤ 30 mL/min/1.73 m2 (trend toward significant at 30-44 mL/min/1.73 m2) 5 • The only referenced meta-analysis found no clinically relevant difference between IOCM and LOCM (defined arbitrarily as a 25% relative risk reduction) but was statistically significant in favor of IOCM. “Clinical relevance” is of particular interest. Even subclinical contrast-induced AKI, as indicated by structural tubular damage, may put patients at higher long-term risks, and specific patient cohorts may be considered for a special management algorithm including IOCM • To increase the safety margins, one may not only consider “high risks” but also “moderate risks” (GFRs of 30-44 mL/min/1.73 m2). In addition, due to poor precision, 10% to 30% of GFR estimates exceed 30% of measured GFRs, and to be 95% certain that measured GFR is > 30 mL/min/1.73 m2, eGFR threshold may need to be at least 45 mL/min/1.73 m2. 2 Every single case of AKI should be worth avoiding. According to the precautionary principle, the burden of proof is placed on those claiming that contrast material at GFRs ≥ 30 mL/min/1.73 m2 is harmless with the present scientific uncertainty.

          Related collections

          Most cited references4

          • Record: found
          • Abstract: found
          • Article: not found

          Current Use of Biomarkers in Acute Kidney Injury: Report and Summary of Recommendations from the 10th Acute Dialysis Quality Initiative Consensus Conference

          Over the last decade there has been considerable progress in the discovery and development of biomarkers of kidney disease, and several have now been evaluated in different clinical settings. While there is a growing literature on the performance of various biomarkers in clinical studies, there is limited information on how these biomarkers would be utilized by clinicians to manage patients with acute kidney injury (AKI). Recognizing this gap in knowledge, we convened the 10th Acute Dialysis Quality Initiative (ADQI) meeting to review the literature on biomarkers in AKI and their application in clinical practice. We asked an international group of experts to assess four broad areas for biomarker utilization for AKI: risk assessment, diagnosis and staging; differential diagnosis; prognosis and management and novel physiological techniques including imaging. This article provides a summary of the key findings and recommendations of the group, to equip clinicians to effectively use biomarkers in AKI.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Use of Intravenous Iodinated Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation

            Intravenous iodinated contrast media are commonly used with CT to evaluate disease and to determine treatment response. The risk of acute kidney injury (AKI) developing in patients with reduced kidney function following exposure to intravenous iodinated contrast media has been overstated. This is due primarily to historic lack of control groups sufficient to separate contrast-induced AKI (CI-AKI; ie, AKI caused by contrast media administration) from contrast-associated AKI (CA-AKI; ie, AKI coincident to contrast media administration). Although the true risk of CI-AKI remains uncertain for patients with severe kidney disease, prophylaxis with intravenous normal saline is indicated for patients who have AKI or an estimated glomerular filtration rate less than 30 mL/min/1.73 m2 who are not undergoing maintenance dialysis. In individual high-risk circumstances, prophylaxis may be considered in patients with an estimated glomerular filtration rate of 30-44 mL/min/1.73 m2 at the discretion of the ordering clinician. This article is a simultaneous joint publication in Radiology and Kidney Medicine. The articles are identical except for stylistic changes in keeping with each journal's style. Either version may be used in citing this article.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Preventing contrast medium-induced acute kidney injury : Side-by-side comparison of Swedish-ESUR guidelines.

              A side-by-side comparison of updated guidelines regarding contrast medium-induced acute kidney injury (CI-AKI) from the Swedish Society of Uroradiology (SSUR) and the European Society of Urogenital Radiology (ESUR) is presented. The major discrepancies include a higher glomerular filtration rate (GFR) threshold as a risk factor for CI-AKI and for discontinuation of metformin by SSUR, i.e., < 45 ml/min versus < 30 ml/min/1.73 m2 by ESUR, when intravenous or intra-arterial contrast media (CM) with second-pass renal exposure is administered. SSUR also continues to recommend consideration of traditional non-renal risk factors such as diabetes and congestive heart failure, while ESUR considers these factors as non-specific for CI-AKI and does not recommend any consideration. Contrary to ESUR, SSUR also recommends discontinuation of NSAID and nephrotoxic medication if possible. Insufficient evidence at the present time motivates the more cautionary attitude taken by SSUR. Furthermore, SSUR expresses GFR thresholds in absolute values in ml/min as recommended by the National Kidney Foundation for drugs excreted by glomerular filtration, while ESUR uses the relative GFR normalised to body surface area in ml/min/1.73 m2. CM dose/GFR ratio thresholds established for coronary angiography/interventions are also applied as recommendations for CM-enhanced CT by SSUR, since SSUR regards coronary procedures as a second-pass renal exposure of CM with no obvious difference in the incidence of AKI compared with IV CM administration. Finally, SSUR recommends reducing the gram-iodine dose/GFR ratio from < 1.0 in patients not at risk to < 0.5 in patients at risk of CI-AKI, while ESUR has no such recommendation. KEY POINTS: • The more cautionary attitude taken by SSUR compared with that of ESUR is motivated by insufficient evidence regarding risk for contrast medium-induced acute kidney injuries (CI-AKI). • SSUR recommends that absolute and not relative GFR should be used when dosing drugs eliminated by the kidneys such as contrast media. • According to SSUR the gram-iodine dose/GFR ratio should be < 0.5 in patients at risk of CI-AKI, while ESUR has no such recommendation.
                Bookmark

                Author and article information

                Journal
                Kidney Med
                Kidney Med
                Kidney Medicine
                Elsevier
                2590-0595
                30 June 2020
                Jul-Aug 2020
                30 June 2020
                : 2
                : 4
                : 500
                Affiliations
                [1 ]Department of Nephrology, Dialysis & Transplantation, International Renal Research Institute (IRRIV), San Bortolo Hospital, Vicenza, Italy
                [2 ]Division of Medical Radiology, Department of Translational Medicine, University of Lund, Malmö, Sweden
                Article
                S2590-0595(20)30116-3
                10.1016/j.xkme.2020.04.009
                7406834
                ddbd5959-b90d-4b82-872d-7117d79cffd5
                © 2020 The Authors

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                Categories
                Letters to the Editor

                Comments

                Comment on this article